Correlation of malondialdehyde concentration with cardiac parameters of different stages of chronic mitral valve disease in dogs
Open Access
- 1 January 2023
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
- Vol. 75 (6) , 1055-1060
Abstract
Malondialdehyde (MDA) is a biomarker of oxidative metabolism, released under situations such as the stretching of atrial myocytes, a fact related to the development of chronic mitral valve disease (MVD) in dogs. This study aimed to evaluate the serum concentration of MDA in dogs at different stages of MVD and correlate it with echocardiographic and radiographic parameters referring to cardiomegaly signs. Thirty-seven dogs were divided into four stages of the disease: GA (n=10), GB1 (n=10), GB2 (n=9), and GC (n=8), following the criteria of the American College of Veterinary Internal Medicine (ACVIM). Blood was collected by jugular puncture and then the serum was frozen for later measurement of MDA concentration by the spectrophotometry technique. No difference was found in MDA concentration between groups despite the presence of cardiac remodeling in dogs at advanced stages of MVD. Moreover, no significant relationship was observed between MDA values and the studied cardiovascular parameters. Serum MDA showed no variation throughout MVD development even with evidence of its release, with no possibility of demonstrating the relationship between its concentration and the cardiovascular alterations caused by the disease in dogs.Keywords
This publication has 23 references indexed in Scilit:
- Prevalence of and Risk Factors for Degenerative Mitral Valve Disease in Dogs Attending Primary-care Veterinary Practices in EnglandJournal of Veterinary Internal Medicine, 2015
- Oxidative Stress in Dilated Cardiomyopathy Caused byMYBPC3MutationOxidative Medicine and Cellular Longevity, 2015
- Historical review, epidemiology and natural history of degenerative mitral valve diseaseJournal of Veterinary Cardiology, 2012
- Malondialdeído e troponina I cardíaca em equinos da raça Puro Sangue Árabe submetidos ao exercício e à suplementação com vitamina ECiência Rural, 2010
- Increased serum oxidative stress in patients with severe mitral regurgitation: A new finding and potential mechanism for atrial enlargementClinical Biochemistry, 2009
- Oxidative stress, antioxidants, and assessment of oxidative stress in dogs and catsJournal of the American Veterinary Medical Association, 2007
- Plasma Antioxidant Capacity in Dogs with Naturally Occurring Heart DiseasesJournal of Veterinary Medicine Series A, 2007
- Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients: relationship to disease severityFree Radical Biology and Medicine, 2002
- Relation of Functional Capacity With the Oxidative Stress and Antioxidants in Chronic Heart FailureCongestive Heart Failure, 2001
- [42] Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal1990